Observational studyAlzheimer's research & therapy2016

Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.

Carina Wattmo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.